Market closed
Cellectar Biosciences Inc./$CLRB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
Ticker
$CLRB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
11
Website
CLRB Metrics
BasicAdvanced
$14M
-
-$1.40
0.97
-
Price and volume
Market cap
$14M
Beta
0.97
52-week high
$0.41
52-week low
$0.23
Average daily volume
1.3M
Financial strength
Current ratio
2.583
Quick ratio
2.481
Long term debt to equity
2.613
Total debt to equity
3.151
Management effectiveness
Return on assets (TTM)
-172.36%
Return on equity (TTM)
-4,693.38%
Valuation
Price to book
0.99
Price to tangible book (TTM)
0.99
Price to free cash flow (TTM)
-0.226
Growth
Earnings per share change (TTM)
-60.10%
3-year earnings per share growth (CAGR)
-31.50%
CLRB News
AllArticlesVideos
Cellectar Biosciences Inc. (CLRB) Q4 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update
GlobeNewsWire·1 month ago
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cellectar Biosciences Inc. stock?
Cellectar Biosciences Inc. (CLRB) has a market cap of $14M as of April 16, 2025.
What is the P/E ratio for Cellectar Biosciences Inc. stock?
The price to earnings (P/E) ratio for Cellectar Biosciences Inc. (CLRB) stock is 0 as of April 16, 2025.
Does Cellectar Biosciences Inc. stock pay dividends?
No, Cellectar Biosciences Inc. (CLRB) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Cellectar Biosciences Inc. dividend payment date?
Cellectar Biosciences Inc. (CLRB) stock does not pay dividends to its shareholders.
What is the beta indicator for Cellectar Biosciences Inc.?
Cellectar Biosciences Inc. (CLRB) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.